tiprankstipranks
Advertisement
Advertisement
MACs’ revised policy positive for iRhythm, says BTIG
PremiumThe FlyMACs’ revised policy positive for iRhythm, says BTIG
28d ago
PANDA Trial Completion Puts iRhythm’s Pediatric Growth Story in Focus
Premium
Company Announcements
PANDA Trial Completion Puts iRhythm’s Pediatric Growth Story in Focus
28d ago
iRhythm price target raised to $157 from $155 at Citi
Premium
The Fly
iRhythm price target raised to $157 from $155 at Citi
1M ago
iRhythm price target lowered to $175 from $215 at JPMorgan
PremiumThe FlyiRhythm price target lowered to $175 from $215 at JPMorgan
1M ago
iRhythm price target lowered to $185 from $225 at Oppenheimer
Premium
The Fly
iRhythm price target lowered to $185 from $225 at Oppenheimer
1M ago
iRhythm price target lowered to $160 from $170 at Evercore ISI
Premium
The Fly
iRhythm price target lowered to $160 from $170 at Evercore ISI
1M ago
iRhythm sees FY26 revenue $875M-$885M, consensus $876.16M
PremiumThe FlyiRhythm sees FY26 revenue $875M-$885M, consensus $876.16M
1M ago
2 Under-the-Radar Wearable AI Stocks Analysts Are Bullish On
Premium
Stock Analysis & Ideas
2 Under-the-Radar Wearable AI Stocks Analysts Are Bullish On
1M ago
iRhythm price target lowered to $170 from $200 at Truist
Premium
The Fly
iRhythm price target lowered to $170 from $200 at Truist
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―